{"slideshow_credits": null, "snippet": "The findings could lead the F.D.A. to revoke the drug\u2019s approval for the treatment of glioblastoma, a rare brain cancer.", "abstract": "Two studies find widely used cancer drug Avastin, sold by Genentech, does not prolong lives of patients with deadly form of brain cancer known as glioblastoma, raising questions about role of drug in treating disease; results could lead Food and Drug Administration to revoke drug's approval for treatment of glioblastoma, much as it did with its approved use for breast cancer.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/03/business/two-studies-challenge-avastins-effectiveness-against-a-rare-brain-cancer.html", "lead_paragraph": "The findings could lead the F.D.A. to revoke the drug\u2019s approval for the treatment of glioblastoma, a rare brain cancer.", "headline": {"seo": "Two Studies Challenge Avastin&#8217;s Effectiveness Against a Rare Brain Cancer", "main": "Two Studies Challenge Avastin\u2019s Effectiveness Against a Rare Brain Cancer", "print_headline": "Two Studies Challenge Avastin\u2019s Effectiveness Against a Rare Brain Cancer"}, "_id": "51abd80440e9ec65d203adc9", "word_count": "846", "multimedia": [], "pub_date": "2013-06-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Avastin (Drug)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Brain Cancer", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Genentech Inc", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Breast Cancer", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Roche Holding A G", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Colon and Colorectal Cancer", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "Cervical Cancer", "name": "subject", "is_major": "N", "rank": "8"}, {"value": "Erbitux (Drug)", "name": "subject", "is_major": "N", "rank": "9"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "News"}